Clinical trial
GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study
NCT00228384 · W.L.Gore & Associates, Industry · Completed
Key facts
| NCT number | NCT00228384 |
|---|---|
| Title | GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study |
| Official title | GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease |
| Lead sponsor | W.L.Gore & Associates, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Diseases |
| Intervention type | Device |
| Interventions | GORE VIABAHN Endoprosthesis, Bare Nitinol Stent |
| Enrollment | 148 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Sep 28, 2005 |
| Last update posted | Jun 4, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: